Tong Ren Tang Healthcare Halts Hong Kong IPO Citing Market Conditions

Edgen Stock·Mar 27 2026, 01:22

Share to

Share to

Copy link

Key Takeaways

Tong Ren Tang Healthcare has postponed its global offering and listing on the Hong Kong Stock Exchange's Main Board, citing adverse market conditions. The decision halts the execution of both international and public underwriting agreements, putting the debut on indefinite hold.

IPO Delayed: Tong Ren Tang Healthcare (02667.HK) has officially delayed its global offering and listing on the HKEX Main Board.
Market Conditions Cited: The company attributed the postponement to unfavorable "current market conditions" as the primary factor.
Agreements Halted: Consequently, the international underwriting agreement will not be signed, and the Hong Kong public offering will not proceed.

Tong Ren Tang Healthcare Postpones HKEX Listing

Tong Ren Tang Healthcare, designated by the ticker 02667.HK, has decided to delay its initial public offering on the Main Board of the Hong Kong Stock Exchange. The company announced its decision to postpone the global offering after assessing various factors, with "current market conditions" being the principal driver behind the move.

Underwriting Agreements Will Not Proceed

The postponement directly impacts the mechanics of the listing process. The international underwriting agreement for the global offering will not be signed. As a result, the conditions for the Hong Kong public offering's underwriting agreement cannot be met, rendering it void. This effectively brings the entire listing plan to a halt until the company decides market conditions have improved.